- Home
- CCSI vs VALN Comparison
CCSI vs VALN Comparison
Compare CCSI & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCSI
- VALN
- Stock Information
- Founded
- CCSI 2021
- VALN 2012
- Country
- CCSI United States
- VALN France
- Employees
- CCSI N/A
- VALN N/A
- Industry
- CCSI Retail: Computer Software & Peripheral Equipment
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCSI Technology
- VALN Health Care
- Exchange
- CCSI Nasdaq
- VALN Nasdaq
- Market Cap
- CCSI 475.1M
- VALN 542.5M
- IPO Year
- CCSI N/A
- VALN 2021
- Fundamental
- Price
- CCSI $22.36
- VALN $6.28
- Analyst Decision
- CCSI Hold
- VALN Strong Buy
- Analyst Count
- CCSI 5
- VALN 3
- Target Price
- CCSI $27.20
- VALN $15.33
- AVG Volume (30 Days)
- CCSI 163.7K
- VALN 80.2K
- Earning Date
- CCSI 05-07-2025
- VALN 05-07-2025
- Dividend Yield
- CCSI N/A
- VALN N/A
- EPS Growth
- CCSI N/A
- VALN N/A
- EPS
- CCSI 4.32
- VALN N/A
- Revenue
- CCSI $349,374,000.00
- VALN $201,099,222.00
- Revenue This Year
- CCSI $1.20
- VALN $18.74
- Revenue Next Year
- CCSI $0.56
- VALN $29.26
- P/E Ratio
- CCSI $5.20
- VALN N/A
- Revenue Growth
- CCSI N/A
- VALN 21.64
- 52 Week Low
- CCSI $15.81
- VALN $3.62
- 52 Week High
- CCSI $32.10
- VALN $8.99
- Technical
- Relative Strength Index (RSI)
- CCSI 53.13
- VALN 45.53
- Support Level
- CCSI $20.86
- VALN $6.18
- Resistance Level
- CCSI $22.90
- VALN $6.42
- Average True Range (ATR)
- CCSI 0.78
- VALN 0.18
- MACD
- CCSI -0.08
- VALN 0.01
- Stochastic Oscillator
- CCSI 55.76
- VALN 23.26
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.